or Try an Advanced Search...

    Technical Analysis for DNLI - Denali Therapeutics Inc.

    Grade Last Price % Change Price Change
    B 24.10 0.04% 0.01
    DNLI closed up 0.04 percent on Friday, July 26, 2024, on 45 percent of normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or a pulls back.
    Earnings due: Aug 6
    *** please verify all earnings dates ***
    3 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Up Up
    Historical DNLI trend table...
    Date Alert Name Type % Chg
    Stochastic Sell Signal Bearish 0.00%
    Upper Bollinger Band Walk Strength 0.00%
    Gapped Up Strength 0.00%
    Overbought Stochastic Strength 0.00%
    Upper Bollinger Band Touch Strength 0.00%
    Pocket Pivot Bullish Swing Setup 0.04%
    Calm After Storm Range Contraction 0.04%
    Overbought Stochastic Strength 0.04%
    Upper Bollinger Band Touch Strength 0.04%
    Calm After Storm Range Contraction 2.08%
    Older End-of-Day Signals for DNLI ...

       Recent Intraday Alerts

    Alert Time
    Gap Up Closed about 17 hours ago
    Reversed from Up about 17 hours ago
    60 Minute Opening Range Breakdown about 17 hours ago
    Rose Above Previous Day's High about 18 hours ago
    Rose Above Upper Bollinger Band about 18 hours ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    DNLI Chart by TradingView
    Basic chart:

    Profile

    Denali Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing therapeutics for neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biopharmaceutical Organ Systems Neuroscience Alzheimer's Disease Parkinson's Disease Neurological Disorders Neurodegenerative Diseases Amyotrophic Lateral Sclerosis Degenerative Disease Neurodegeneration Senescence

    Is DNLI a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Jul 23 Denali Therapeutics (DNLI) Stock Jumps 9.7%: Will It Continue to Soar?
    Jul 16 Denali Therapeutics Stock Gets Technical Rating Upgrade
    Jul 8 3 Longevity Stocks to Buy for Anti-Aging Breakthroughs
    Jun 28 Denali (DNLI) Outperforms Industry in 3 Months: Here's Why
    Jun 24 Denali Therapeutics (DNLI) Moves 5.8% Higher: Will This Strength Last?
    Jun 15 ALS therapy market seen increasing to nearly $1.3B by 2029
    Jun 7 Why Is Prothena (PRTA) Down 1.5% Since Last Earnings Report?
    Jun 7 Companies Like Denali Therapeutics (NASDAQ:DNLI) Are In A Position To Invest In Growth
    Jun 6 Denali: Cash, Big Pharma Partnerships And High Potential For MPS-II Do Not Warrant A Buy
    Jun 6 Why Is Denali Therapeutics (DNLI) Up 15.6% Since Last Earnings Report?
    See more DNLI news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 28.745
    52 Week Low 14.56
    Average Volume 1,214,380
    200-Day Moving Average 19.54
    50-Day Moving Average 21.47
    20-Day Moving Average 22.59
    10-Day Moving Average 23.27
    Average True Range 1.13
    RSI (14) 60.78
    ADX 23.24
    +DI 32.73
    -DI 17.09
    Chandelier Exit (Long, 3 ATRs) 21.50
    Chandelier Exit (Short, 3 ATRs) 23.81
    Upper Bollinger Bands 24.77
    Lower Bollinger Band 20.42
    Percent B (%b) 0.85
    BandWidth 19.25
    MACD Line 0.69
    MACD Signal Line 0.59
    MACD Histogram 0.0996
    Fundamentals Value
    Market Cap 3.33 Billion
    Num Shares 138 Million
    EPS -0.94
    Price-to-Earnings (P/E) Ratio -25.64
    Price-to-Sales 7.32
    Price-to-Book 2.23
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 25.63
    Resistance 3 (R3) 25.72 25.30 25.38
    Resistance 2 (R2) 25.30 24.91 25.26 25.29
    Resistance 1 (R1) 24.70 24.67 24.49 24.61 25.20
    Pivot Point 24.28 24.28 24.18 24.24 24.28
    Support 1 (S1) 23.68 23.89 23.47 23.59 23.00
    Support 2 (S2) 23.26 23.65 23.22 22.91
    Support 3 (S3) 22.66 23.26 22.83
    Support 4 (S4) 22.57